The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of sorafenib in combination with local microtherapy guided by gadolinium-EOB-DTPA enhanced MRI in patients with inoperable hepatocellular carcinoma.
J. Ricke
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Research Funding - Bayer; Sirtex Medical
K. Schuette
Honoraria - Bayer
Research Funding - Bayer; Sirtex Medical
I. W. Graziadei
Research Funding - Bayer; Sirtex Medical
A. Jakob
Research Funding - Bayer; Sirtex Medical
C. Verslype
Research Funding - Bayer; Sirtex Medical
B. Sangro
Research Funding - Bayer; Sirtex Medical
J. Walecki
Research Funding - Bayer; Sirtex Medical
H. J. Klümpen
Research Funding - Bayer; Sirtex Medical
B. Peynircioglu
Research Funding - Bayer; Sirtex Medical
S. Yalcin
Research Funding - Bayer; Sirtex Medical
C. Bartolozzi
Research Funding - Bayer; Sirtex Medical
H. Amthauer
Research Funding - Bayer; Sirtex Medical
P. Malfertheiner
Research Funding - Bayer; Sirtex Medical